|
1
|
Bashir MN and Malik MA: Case-control study
of diet and prostate cancer in a rural population of Faisalabad,
Pakistan. Asian Pac J Cancer Prev. 16:2375–2378. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bettuzzi S, Brausi M, Rizzi F, Castagnetti
G, Peracchia G and Corti A: Chemoprevention of human prostate
cancer by oral administration of green tea catechins in volunteers
with high-grade prostate intraepithelial neoplasia: A preliminary
report from a one-year proof-of-principle study. Cancer Res.
66:1234–1240. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jannini EA, Gravina GL, Morgentaler A,
Morales A, Incrocci L and Hellstrom WJ: Is testosterone a friend or
a foe of the prostate? J Sex Med. 8:946–955. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Loch T: Prostate cancer diagnostics:
Innovative imaging in case of multiple negative biopsies. World J
Urol. 29:607–614. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saunders EJ, Dadaev T, Leongamornlert DA,
JugurnauthLittle S, Tymrakiewicz M, Wiklund F, Al Olama AA,
Benlloch S, Neal DE, Hamdy FC, et al: Fine-mapping the HOXB region
detects common variants tagging a rare coding allele: Evidence for
synthetic association in prostate cancer. PLoS Genet.
10:e10041292014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sverrisson EF, Zens MS, Fei DL, Andrews A,
Schned A, Robbins D, Kelsey KT, Li H, DiRenzo J, Karagas MR and
Seigne JD: Clinicopathological correlates of Gli1 expression in a
population-based cohort of patients with newly diagnosed bladder
cancer. Urol Oncol. 32:539–545. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cullen J, Elsamanoudi S, Brassell SA, Chen
Y, Colombo M, Srivastava A and McLeod DG: The burden of prostate
cancer in Asian nations. J Carcinog. 11:72012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Center MM, Jemal A, LortetTieulent J, Ward
E, Ferlay J, Brawley O and Bray F: International variation in
prostate cancer incidence and mortality rates. Eur Urol.
61:1079–1092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsilidis KK, Papadimitriou N, Capothanassi
D, Bamia C, Benetou V, Jenab M, Freisling H, Kee F, Nelen A,
O'Doherty MG, et al: Burden of cancer in a large consortium of
prospective cohorts in Europe. J Natl Cancer Inst. 108:djw1272016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bray F, Jemal A, Grey N, Ferlay J and
Forman D: Global cancer transitions according to the Human
development index (2008-2030): A population-based study. Lancet
Oncol. 13:790–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bianchi E, Caldwell ME and Cole JR:
Antitumor agents from Bursera microphylla (Burseraceae) I.
Isolation and characterization of deoxypodophyllotoxin. J Pharm
Sci. 57:696–697. 1968. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khaled M, Jiang ZZ and Zhang LY:
Deoxypodophyllotoxin: A promising therapeutic agent from herbal
medicine. J Ethnopharmacol. 149:24–34. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu TT and Huang JK: The clinical
usefulness of prostate-specific antigen (PSA) level and
age-specific PSA reference ranges for detecting prostate cancer in
Chinese. Urol Int. 72:208–211. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shin SY, Yong Y, Kim CG, Lee YH and Lim Y:
Deoxypodophyllotoxin induces G2/M cell cycle arrest and apoptosis
in HeLa cells. Cancer Lett. 287:231–239. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Benzina S, Harquail J, Jean S, Beauregard
AP, Colquhoun CD, Carroll M, Bos A, Gray CA and Robichaud GA:
Deoxypodophyllotoxin isolated from Juniperus communis induces
apoptosis in breast cancer cells. Anticancer Agents Med Chem.
15:79–88. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu M, Jiang Z, Duan H, Sun L, Zhang S,
Chen M, Wang Y, Gao Q, Song Y, Zhu X and Zhang L:
Deoxypodophyllotoxin triggers necroptosis in human non-small cell
lung cancer NCI-H460 cells. Biomed Pharmacother. 67:701–706. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fan JH, Feng GG, Huang L, Tang GD, Jiang
HX and Xu J: Naofen promotes TNF-α-mediated apoptosis of
hepatocytes by activating caspase-3 in lipopolysaccharide-treated
rats. World J Gastroenterol. 20:4963–4971. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamamoto Y, Koma H, Hiramatsu H, Abe M,
Murakami K, Ohya A and Yagami T: Treatment of etoposide combined
with 15-deoxy-Δ12,14-prostaglandin J2 exerted synergistic antitumor
effects against renal cell carcinoma via peroxisome
proliferator-activated receptor-γ-independent pathways. Mol Clin
Oncol. 2:292–296. 2014.PubMed/NCBI
|
|
19
|
Carrillo García C, Riedt T, Li J, Dotten
M, Brossart P and Janzen V: Simultaneous deletion of p21Cip1/Waf1
and caspase-3 accelerates proliferation and partially rescues the
differentiation defects of caspase-3 deficient hematopoietic stem
cells. PLoS One. 9:e1092662014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sang CY, Xu XH, Qin WW, Liu JF, Hui L and
Chen SW: DPMA, a deoxypodophyllotoxin derivative, induces apoptosis
and anti-angiogenesis in non-small cell lung cancer A549 cells.
Bioorg Med Chem Lett. 23:6650–6655. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yong Y, Shin SY, Lee YH and Lim Y:
Antitumor activity of deoxypodophyllotoxin isolated from Anthriscus
sylvestris: Induction of G2/M cell cycle arrest and
caspase-dependent apoptosis. Bioorg Med Chem Lett. 19:4367–4371.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee JH, Cho HD, Jeong IY, Lee MK and Seo
KI: Sensitization of tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL)-resistant primary prostate cancer
cells by isoegomaketone from Perilla frutescens. J Nat Prod.
77:2438–2443. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Smith B, Randle D, Mezencev R, Thomas L,
Hinton C and Odero-Marah V: Camalexin-induced apoptosis in prostate
cancer cells involves alterations of expression and activity of
lysosomal protease cathepsin D. Molecules. 19:3988–4005. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wakabayashi K, Saito H, Ebinuma H, Saito
Y, Takagi T, Nakamura M, Umezawa A, Hata J and Ishii H: Bcl-2
related proteins are dramatically induced at the early stage of
differentiation in human liver cancer cells by a histone
deacetylase inhibitor projecting an anti-apoptotic role during this
period. Oncol Rep. 7:285–288. 2000.PubMed/NCBI
|
|
25
|
Yeh YC, Liu TJ and Lai HC: Shikonin
induces apoptosis, necrosis, and premature senescence of human A549
lung cancer cells through Upregulation of p53 Expression. Evid
Based Complement Alternat Med. 2015:6203832015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nishimura R, Arima N, Toyoshima S, Ohi Y,
Anan K, Sagara Y, Mitsuyama S and Tamura K: Evaluation of PTEN loss
and PIK3CA mutations and their correlation with efficacy of
trastuzumab treatment in HER2-positive metastatic breast cancer: A
retrospective study (KBC-SG 1001). Mol Clin Oncol. 1:47–52.
2013.PubMed/NCBI
|
|
27
|
Jung S, Li C, Jeong D, Lee S, Ohk J, Park
M, Han S, Duan J, Kim C, Yang Y, et al: Oncogenic function of
p34SEI-1 via NEDD4-1-mediated PTEN ubiquitination/degradation and
activation of the PI3K/AKT pathway. Int J Oncol. 43:1587–1595.
2013.PubMed/NCBI
|
|
28
|
Hancox U, Cosulich S, Hanson L, Trigwell
C, Lenaghan C, Ellston R, Dry H, Crafter C, Barlaam B, Fitzek M, et
al: Inhibition of PI3Kβ signaling with AZD8186 inhibits growth of
PTEN-deficient breast and prostate tumors alone and in combination
with docetaxel. Mol Cancer Ther. 14:48–58. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ghalali A, Wiklund F, Zheng H, Stenius U
and Högberg J: Atorvastatin prevents ATP-driven invasiveness via
P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells.
Carcinogenesis. 35:1547–1555. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu Z, McRoberts KS and Theodorescu D: The
role of PTEN in prostate cancer cell tropism to the bone
micro-environment. Carcinogenesis. 28:1393–1400. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schmitz M, Grignard G, Margue C, Dippel W,
Capesius C, Mossong J, Nathan M, Giacchi S, Scheiden R and Kieffer
N: Complete loss of PTEN expression as a possible early prognostic
marker for prostate cancer metastasis. Int J Cancer. 120:1284–1292.
2007. View Article : Google Scholar : PubMed/NCBI
|
